AnandRathi

Alivus Life Sciences Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
1,357.70
-4.40 (-0.32%)

Alivus Life Sciences Ltd (Alivus Life) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹16,669 crore.

Alivus Life Sciences Ltd Overview

Market cap₹16,669 Crs
Volume3,514
Prev. Close₹1,362.10
Year range₹830.00 - ₹1,415.90
Total Value₹47,70,957.80
ISININE03Q201024

Alivus Life Sciences Ltd Fundamental Analysis

ROCE(TTM)22.33%
P/E Ratio (TTM)27.64
P/B Ratio5.00
Debt to Equity0.02
ROE16.94%
EPS (TTM)50.64
Dividend Yield0.37%
Book Value271.41
Profit Margin24.00%
Operating Margin29.25%

Alivus Life Sciences Ltd Historical Performance

1 Month Return20.10%
6 Month Return48.69%
3 Year Return119.76%
3 Month Return26.84%
1 Year Return43.00%
5 Year Return100.21%

Alivus Life Sciences Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research